4.6 Article

Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation-Recommendations from a Consensus Conference

Journal

Publisher

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.01030115

Keywords

-

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5K23-DK87937, U01-DK085587, R01-DK079665, R01-DK085185, R01-DK096008, K24-DK101828]
  2. National Institute of Allergy and Infections Diseases/NIDDK [R03-DK091786]
  3. Health Resources and Services Administration Grant [R39-OT22059]
  4. National Institute of Nursing Research Grant [R21-NR013660]

Ask authors/readers for more resources

The Best Practice in Live Kidney Donation Consensus Conference held in June of 2014 included the Best Practices in Living Donor Education Workgroup, whose charge was to identify best practice strategies in education of living donors, community outreach initiatives, commercial media, solicitation, and state registries. The workgroup's goal was to identify critical content to include in living kidney donor education and best methods to deliver educational content. A detailed summary of considerations regarding educational content issues for potential living kidney donors is presented, including the consensus that was reached. Educational topics that may require updating on the basis of emerging studies on living kidney donor health outcomes are also presented. Enhancing the educational process is important for increasing living donor comprehension to optimize informed decision-making.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy

Al-Faraaz Kassam, Ahmad Mirza, Young Kim, Dennis Hanseman, E. Steve Woodle, Ralph C. Quillin, Bobby L. Johnson, Amit Govil, Michael Cardi, Daniel P. Schauer, Eric P. Smith, Tayyab S. Diwan

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Surgery

Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial

E. Steve Woodle, Dixon B. Kaufman, Adele R. Shields, John Leone, Arthur Matas, Alexander Wiseman, Patricia West-Thielke, Ting Sa, Eileen C. King, Rita R. Alloway

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Review Surgery

Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement

David P. Al-Adra, Laura Hammel, John Roberts, E. Steve Woodle, Deborah Levine, Didier Mandelbrot, Elizabeth Verna, Jayme Locke, Jonathan D'Cunha, Maryjane Farr, Deirdre Sawinski, Piyush K. Agarwal, Jennifer Plichta, Sandhya Pruthi, Deborah Farr, Richard Carvajal, John Walker, Fiona Zwald, Thomas Habermann, Morie Gertz, Philip Bierman, Don S. Dizon, Carrie Langstraat, Talal Al-Qaoud, Scott Eggener, John P. Richgels, George J. Chang, Cristina Geltzeiler, Gonzalo Sapisochin, Rocco Ricciardi, Alexander S. Krupnick, Cassie Kennedy, Nisha Mohindra, David P. Foley, Kymberly D. Watt

Summary: This article discusses the evaluation of solid organ transplantation for patients with a history of malignancy, emphasizing the need to balance the benefits of transplantation and the risk of tumor recurrence. It also points out that previous guidelines do not fully consider current staging, disease biology, and advances in cancer treatments.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Surgery

Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement

David P. Al-Adra, Laura Hammel, John Roberts, E. Steve Woodle, Deborah Levine, Didier Mandelbrot, Elizabeth Verna, Jayme Locke, Jonathan D'Cunha, Maryjane Farr, Deirdre Sawinski, Piyush K. Agarwal, Jennifer Plichta, Sandhya Pruthi, Deborah Farr, Richard Carvajal, John Walker, Fiona Zwald, Thomas Habermann, Morie Gertz, Philip Bierman, Don S. Dizon, Carrie Langstraat, Talal Al-Qaoud, Scott Eggener, John P. Richgels, George J. Chang, Cristina Geltzeiler, Gonzalo Sapisochin, Rocco Ricciardi, Alexander S. Krupnick, Cassie Kennedy, Nisha Mohindra, David P. Foley, Kymberly D. Watt

Summary: This document reviews prognosis, treatment, and transplant recommendations for patients with a history of malignancy undergoing solid organ transplantation. It also addresses the potential effects of immunosuppression on cancer-specific outcomes.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients

Allan D. Kirk, Andrew B. Adams, Antoine Durrbach, Mandy L. Ford, David A. Hildeman, Christian P. Larsen, Flavio Vincenti, David Wojciechowski, E. Steve Woodle

Summary: Kidney transplant recipients administered belatacept-based maintenance immunosuppression show a more favorable metabolic profile, but have higher rates of early cellular rejection. Further clinical trials are needed to determine the optimal alternative belatacept-based regimen.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients Long-term Outcomes of a Randomized Clinical Trial

E. Steve Woodle, John S. Gill, Stephanie Clark, Darren Stewart, Rita Alloway, Roy First

Summary: This study compared the long-term outcomes of kidney transplant patients randomized to continue or withdraw corticosteroids, and found that long-term corticosteroids may not be necessary for low- to moderate-immune risk kidney transplant recipients as part of an immunosuppressive regimen.

JAMA SURGERY (2021)

Article Urology & Nephrology

Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial

Dixon B. Kaufman, E. Steve Woodle, Adele Rike Shields, John Leone, Arthur Matas, Alexander Wiseman, Patricia West-Thielke, Ting Sa, Eileen C. King, Rita R. Alloway

Summary: The study compared the outcomes of kidney transplant patients receiving belatacept versus tacrolimus for maintenance immunosuppression with rapid steroid withdrawal over a period of 2 years. The results showed similar patient and graft survival rates between the groups, but a significantly lower incidence of eGFR <45 ml/min per 1.73 m(2) in the belatacept group and a significantly higher incidence of biopsy-proven acute rejection.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Review Immunology

Plasma cell biology: Foundations for targeted therapeutic development in transplantation

Amy P. Rossi, Rita R. Alloway, David Hildeman, E. Steve Woodle

Summary: Solid organ transplantation is a life-saving procedure that has made significant progress in the past 70 years, particularly in T-cell-targeted immunosuppression and organ allocation systems. However, humoral alloimmune responses remain a major challenge, especially for patients with preexisting anti-HLA antibodies. Therapies to target plasma cells, the source of antibody production, have had limited effectiveness in reducing antibody levels.

IMMUNOLOGICAL REVIEWS (2021)

Article Urology & Nephrology

Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation

Rajasree Menon, Andrew S. Bomback, Blue B. Lake, Christy Stutzke, Stephanie M. Grewenow, Steven Menez, Vivette D. D'Agati, Sanjay Jain

KIDNEY INTERNATIONAL (2022)

Article Transplantation

The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts

Bassam G. Abu Jawdeh, Begona Campos-Naciff, Karthikeyan Meganathan, E. Steve Woodle, Bradley P. Dixon

Summary: This study investigates the potential of complement split-products (CSP) as biomarkers for acute antibody-mediated rejection (AMR). The results did not support the utility of CSP as surrogate biomarkers for AMR. However, larger studies are needed to confirm these findings.

TRANSPLANTATION DIRECT (2022)

Article Immunology

Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates

Alin L. Girnita, Lin Wang, Adriana Colovai, Patrick Ahearn, Yorg Azzi, Madhav C. Menon, Marcelo Fernandez-Vina, Howard M. Gebel, E. Steve Woodle, Paolo Cravedi, Jonathan S. Maltzman, Enver Akalin

Summary: This study investigated the changes in anti-HLA antibodies in kidney transplant recipients after COVID-19 and compared them with anti-SARS-CoV-2 antibodies. The results showed that anti-HLA antibodies were mainly IgG, while anti-SARS-CoV-2 antibodies had a high IgA/IgM profile.

TRANSPLANTATION (2022)

Article Pediatrics

Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients

Ellen M. Cody, Charles Varnell Jr, Danielle Lazear, Katherine VandenHeuvel, Francisco X. Flores, E. Steve Woodle, David K. Hooper

Summary: Two pediatric patients with kidney transplant who experienced rejection due to antibodies were treated with the second generation proteasome inhibitor carfilzomib. One patient, a two-year-old female, recovered after completing three cycles of treatment, while the other patient, a 17-year-old female, showed improvement after two cycles of treatment.

PEDIATRIC TRANSPLANTATION (2023)

Meeting Abstract Surgery

The Role of Complement-Split Products as Biomarkers for Acute Antibody-Mediated Rejection of Kidney Allografts

B. G. Abu Jawdeh, B. Campos-Naciff, K. Harrison, K. Meganathan, A. Kumar, M. Anand, A. Govil, E. S. Woodle, B. P. Dixon

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Meeting Abstract Surgery

A Prospective Randomized Multicenter Trial (BEST Trial) of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression: Infectious Complications

P. West-Thielke, A. Shields, D. Kaufman, J. Leone, A. Wiseman, A. Matas, T. Sa, E. King, R. Alloway, S. Woodle

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Meeting Abstract Surgery

Belatacept-Based Regimens: Induction and Recipient Gender Influence Outcomes

N. Wilson, A. R. Shields, A. Wiseman, A. L. Christianson, S. Tremblay, D. Kaufman, J. P. Leone, A. J. Matas, P. West-Thielke, R. R. Alloway, E. S. Woodle

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

No Data Available